Adverse event totals12

The totals the trial posted for each group.

1 to 12 of 12

Total	Group	Affected	At risk
Total, all-cause mortality	BMS-986036 10 mg	1	39
Total, all-cause mortality	BMS-986036 20 mg	0	38
Total, all-cause mortality	BMS-986036 40 mg	0	39
Total, all-cause mortality	Placebo	1	39
Total, other adverse events	BMS-986036 10 mg	27	39
Total, other adverse events	BMS-986036 20 mg	36	37
Total, other adverse events	BMS-986036 40 mg	29	39
Total, other adverse events	Placebo	33	39
Total, serious adverse events	BMS-986036 10 mg	7	39
Total, serious adverse events	BMS-986036 20 mg	7	37
Total, serious adverse events	BMS-986036 40 mg	8	39
Total, serious adverse events	Placebo	3	39

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03486912/event-totals